Brief: Solid Biosciences, Phlox Therapeutics Collaborates On Accelerating New Therapies For Rare Cardiac Diseases
Jan 11 (Reuters) - Solid Biosciences Inc SLDB.O :
* SOLID BIOSCIENCES AND PHLOX THERAPEUTICS ANNOUNCE
STRATEGIC
RESEARCH COLLABORATION FOCUSED ON ACCELERATING DEVELOPMENT OF
NEW THERAPIES FOR RARE CARDIAC DISEASES
Source text for Eikon: ID:nGNX6X8rT7
Further company coverage: SLDB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solid Biosciences
See all newsSolid Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Solid Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview
Solid Biosciences Q2 net loss widens on higher R&D costs
Marketing Agreement To Advance Gene Therapy Delivery And Analytics
Solid Biosciences Q1 net loss widens on higher R&D costs